BIOA BioAge Labs, Inc.

NASDAQ
$4.71

BioAge Labs, Inc. (BIOA) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is a loss of $0.76 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -11.3% since its last earnings release on November 5, 2026.

BioAge Labs Missed Consensus Estimates
Thursday, November 5, 2026 · 4:30 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:30 PM ET
Earnings Whisper
-
vs ($0.76)
Rev est $900K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $5.42

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BioAge Labs, Inc.

BioAmber Inc is an industrial biotechnology company producing sustainable chemicals. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.